BMK1/ERK5 is a novel regulator of angiogenesis by destabilizing hypoxia inducible factor 1α

Circulation Research

Volumn 96, Issue 11, 2005, Pages 1145-1151

  Pi, Xinchun ^a   Garin, Gwenaele ^a   Xie, Liang ^b   Zheng, Qinlei ^a   Wei, Heng ^a   Abe, Jun Ichi ^a   Yan, Chen ^a   Berk, Bradford C ^a,c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c Cardiology Unit   (United States)

Author keywords

Angiogenesis; Big MAP kinase 1; Hypoxia inducible factor 1

Indexed keywords

ACETYL LEUCINAL LEUCINAL NONLEUCINAL; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; ENZYME INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTACYSTIN; MITOGEN ACTIVATED PROTEIN KINASE 7; UBIQUITIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; COW; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HYPOXIA; LUNG BLOOD VESSEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REGULATORY MECHANISM; UBIQUITINATION;

ANIMALS; APOPTOSIS; CATTLE; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 7; NEOVASCULARIZATION, PHYSIOLOGIC; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UBIQUITIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 20444489156     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000168802.43528.e1     Document Type: Article

References (26)

1. Jain RK. Molecular regulation of vessel maturation. Nat Med. 2003;9: 685-693.
2. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9: 653-660.
3. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 1992;359:845-848.
4. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-845.
5. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol. 1999;15:551-578.
6. Minet E, Arnould T, Michel G, Roland I, Mottet D, Raes M, Remacle J, Michiels C. ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett. 2000;468:53-58.
7. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 1998;12:149-162.
8. Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 2001;294:1337-1340.
9. Semenza G. Signal transduction to hypoxia-indudble factor 1. Biochem Pharmacol. 2002;64:993-998.
10. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003;9:677-684.
11. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol. 2004;5:343-354.
12. Richard DE, Berra E, Gothie E, Roux D, Pouyssegur J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem. 1999;274:32631-32637.
13. Berra E, Milanini J, Richard DE, Le Gall M, Vinals F, Gothie E, Roux D, Pages G, Pouyssegur J. Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem Pharmacol. 2000;60:1171-1178.
14. Pages G, Guerin S, Grall D, Bonino F, Smith A, Anjuere F, Auberger P, Pouyssegur J. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science. 1999;286:1374-1377.
15. Sohn SJ, Sarvis BK, Cado D, Winoto A. ERK5 MAPK regulates embryonicangiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression. J Biol Chem. 2002;277: 43344-43351.
16. Hayashi M, Kim SW, Imanaka-Yoshida K, Yoshida T, Abel ED, Eliceiri B, Yang Y, Ulevitch RJ, Lee JD. Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J Clin Invest. 2004;113:1138-1148.
17. Pi X, Yan C, Berk BC. Big Mitogen-Activated Protein Kinase (BMK1)TERK5 Protects Endothelial Cells From Apoptosis. Circ Res. 2004;94:362-369.
18. Armesilla AL, Lorenzo E, Gomez del Arco P, Martinez-Martinez S, Alfranca A, Redondo JM. Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: a role for tissue factor gene expression. Mol Cell Biol. 1999;19:2032-2043.
19. Kim D, Rybalkin SD, Pi X, Wang Y, Zhang C, Munzel T, Beavo JA, Berk BC, Yan C. Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance. Circulation. 2001;104:2338-2343.
20. Poppa V, Miyashiro JK, Corson MA, Berk BC. Endothelial NO synthase is increased in regenerating endothelium after denuding injury of the rat aorta. Arterioscler Thromb Vasc Biol 1998;18:1312-1321.
21. Yan C, Takahashi M, Okuda M, Lee JD, Berk BC. Fluid shear stress stimulates big mitogen-activated protein kinase 1 (BMK1) activity in endothelial cells. Dependence on tyrosine kinases and intracellular calcium. J Biol Chem. 1999;274:143-150.
22. Yamakawa M, Liu LX, Date T, Belanger AJ, Vincent KA, Akita GY, Kuriyama T, Cheng SH, Gregory RJ, Jiang C. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res. 2003;93:664-673.
23. 2 sensing. Science. 2001;292:464-468.
24. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292:468-472.
25. Yu F, White SB, Zhao Q, Lee FS. HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci U S A. 2001;98:9630-9635.
26. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science. 2002;295:858-861.